The Mitochondrial Medicine Society

Advancing education, research, and global collaboration in clinical mitochondrial medicine

Mitochondrial Disease and Life Span

For 2022 and 2023, the MMS is studying the life span and events that occur around the time of end of life in mitochondrial patients around the world. The study is almost complete and a publication is expected by the end of the year.

Omavelaxolone approved for Friedreich Ataxia

We are happy to report that Omavelaxolone has been approved for Friedreich Ataxia. A statement from our Medical Board is attached.

Elections 2022

Congratulations to our newly selected officers, instated at the June UMDF meeting:

President, Mary Kay Koenig

Secretary, Ralitza Gavrilova

Program Chair, Fernando Scaglia

International Councilor: Shamima Rahman (UK)

MMS Board: Active Past-Presidents including Amel Karaa, Amy Goldstein and Sumit Parikh

Free CME At Mito U

The MMS has partnered with the UMDF to create an online curriculum that offers CME courses on basic and advanced mitochondrial disease topics. More information is available online at Mito University (Mito U) at this link. Our aim is to provide a central place to find up-to-date peer-reviewed educational information that will be continually kept up-to-date.

COVID19

  1. An International Statement from the MMS and partnering medical specialty organizations providing guidance on the COVID19 vaccine for Mitochondrial Disease Patients - at this link. This statement will be updated as new information is received (last updated March 2021).

  2. MMS Guidance on Mitochondrial Disease Patients Returning to School during the COVID19 Pandemic - at this link

New publications

New MMS publications are now available

  1. On the safety of medication in mitochondrial disease - in the Journal of Inherited Metabolic Disorders - at this link

  2. On the reasons the term “possible” mitochondrial disease should not be used - in the Journal of Medical Genetics - at this link

  3. On how we formed the US Mitochondrial Disease Care Network - in Molecular Genetics & Metabolism - at this link

  4. A history of the MMS - in M3 - available at this link

Mitochondrial Care Network Launched   

Read more here

Publication and Project Update

  • The MMS is working on reclassifying the diagnosis of "Possible" Mitochondrial Disease. More to come in 2019

  • The MMS has developed Preventative Care Guidelines for patients with Mitochondrial Disease. The publication is in Genetics in Medicine and available here.

  • Formal treatment guidelines for the Management of stroke in MELAS are now available at JAMA Neurology. For more information, click here.

  • The MMS has looked at Solid-organ transplant outcomes in primary mitochondrial disease. The publication is available here

  • Mitochondrial Case Studies, a clinician friendly review of the presentations, differential, pathophysiology and treatment approaches of some of the most common (and some uncommon) mitochondrial diseases is now available on Elsevier. The editors include several of the past-Presidents of the MMS with chapters written by MMS members. See more at this link.

  • The MMS North American Consensus Criteria for the Diagnosis and Treatment of Mitochondrial Disease are now available in the journal Genetics in Medicine. Click here to see more.

Fellowship in Mitochondrial Medicine

The North American Mitochondrial Disease Consortium (NAMDC) fellowship is soliciting applications. Read more here